Endo attempts to outbid Valeant for Salix Pharma
March 12, 2015Sales and Marketing Endo, Valeant, merger, outbid, pharma, salix
Endo has joined the race for Salix, the firm that Valeant reached a $14.5 billion agreement to purchase last month. …
GSK picks Singapore for Asian hub
March 12, 2015Manufacturing and Production, Research and Development, Sales and Marketing Asia, GSK, Singapore, Takeda, Witty, emerging markets
Despite GlaxoSmithKline’s ongoing troubles in Asia it has decided to establish a new HQ in Singapore to bolster its presence …
UCB sponsors ‘Hack Epilepsy’ digital event
March 12, 2015Medical Communications, Sales and Marketing Keppra, UCB, epilepsy, hack, lacosamide, levetiracetam, vimpat
Belgian biopharma firm UCB says it will be sponsoring a ‘Hack Epilepsy’ event this year to help support patient needs …
Adaptimmune appoints PwC head to board
March 12, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lawrence Alleva, adaptimune, pwC
Clinical-stage biotech firm Adaptimmune has appointed Lawrence Alleva as a non-executive director who is also to serve as chairman of its …
Merck’s cancer drug sees first ever early access nod
March 11, 2015Sales and Marketing Cancer, ICR, Merck, eams, early access, keytruda, melanoma, oncology, pembrolizumab
Merck’s skin cancer drug Keytruda has become the first drug to be approved through the new Early Access to Medicines …
Merck Serono bets on precision medicine
March 11, 2015Sales and Marketing AstraZeneca, Diagnostics, FDA, Illumina, Merck Serono, opexa, personalised
Merck Serono is looking to expand further into personalised medicine as the company enters into an agreement with Illumina to …
GSK China scandal leads to staff conflict
March 11, 2015Sales and Marketing China, GSK, GlaxoSmithKline, bribery, chinese, cuts, sacked
Around 135 workers who face being removed from their posts by GlaxoSmithKline due to misconduct centering on bribery scandals in …
Government pledges ‘new era’ for NHS
March 11, 2015Research and Development, Sales and Marketing NHS, Simon Stevens, five year, reform, reorganisation, vanguard
The government is investing £200 million to back healthcare professionals to implement their own ideas for improving patient care. The …
New details of Innovative Medicines review disclosed
March 11, 2015Research and Development, Sales and Marketing ABPI, NHS, NICE, PPRS, UK, george freeman, innovative medicines
The government has announced details of a sweeping review into how medicines are accessed in the UK. The Innovative Medicines …
NICE approves Roche’s Gazyvaro and Novartis’ Xolair
March 11, 2015Research and Development, Sales and Marketing Gazyvaro, NICE, Novartis, Roche, Xolair, obinutuzumab, omalizumab
NICE today gave the green light to three new biological drugs, after recommending Roche’s Gazyvaro, GSK’s Arzerra and Novartis’ Xolair …
New head of digital for Virgo Health
March 11, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Virgo HEALTH, tom griffiths
UK-based healthcare comms agency Virgo Health has increased its leadership team through the appointment of Tom Griffiths as head of digital. …
HRT pills linked to increase in clots and strokes
March 10, 2015Research and Development, Sales and Marketing Cochrane, HRT, boardman, hormone replacement therapy
HRT tablets do not offer heart benefits and slightly increase the risk of strokes and blood clots in some women. …
German court rules against Lilly in Alimta patent case
March 10, 2015Manufacturing and Production, Sales and Marketing ACS, Actavis, Alimta, NICE, NSCLC, lilly, lung cancer, pemetrexed
A German court has ruled that Lilly’s patent for its lung cancer drug Alimta would not be infringed by generic …
$10 generic Solvaldi emerges in Bangladesh
March 10, 2015Manufacturing and Production, Sales and Marketing Gilead, World Trade Organization, hep C, incepta, sofosbuvir, sofosbuvir), sovaldi
A Bangladeshi pharma company is producing an unlicensed generic version of Gilead’s hepatitis C drug Sovaldi for $10 per pill …
FDA gives new safety warning on Pfizer’s Champix
March 10, 2015Manufacturing and Production, Sales and Marketing Champix, Cochrane, FDA, MHRA, Pfizer, varenicline
The FDA has warned that Pfizer’s stop smoking drug Champix is linked with seizures, aggressive behaviour and blackouts. In its …
Apple highlights ‘ResearchKit’ through watch launch
March 10, 2015Medical Communications, Sales and Marketing Apple, FDA, digital, health, healthkit, researchkit, wearables
US tech giant Apple has finally launched its digital wearable device along with a ResearchKit platform that allows apps to …
Oncologists say CDF cuts will compromise treatment
March 10, 2015Sales and Marketing CDF, Jevtana, NHS, NICE, Sanofi, cabazitaxel, doctors.net, m3
Oncologists believe cutting drugs from the Cancer Drugs Fund won’t save the NHS money and will worsen patient outcomes according …
Sanofi names audit committee chairman
March 10, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Robert Castaigne, Sanofi
Sanofi has looked to its own board to fulfil the role of chairman as it names Robert Castaigne chairman of …
Targacept and Catalyst sign $100 million deal
March 9, 2015Research and Development, Sales and Marketing CB 813d, PF-05280602, Targecept, blood disorder, catalyst biosciences
Targacept and Catalyst Biosciences have signed a merger agreement which will see them develop new treatment options for patients with …
Novo Nordisk obesity drug shows added benefits
March 9, 2015Sales and Marketing (liraglutide), Contrave, Novo Nordisk, Victoza, Xenical, liraglutide, obesity, saxenda, weight
New research by Novo Nordisk has suggested that its obesity drug Saxenda can help improve several other weight-related problems as …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
